Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Prakash

Showing results (291-300 of 339) with videos related to

Pageof 34
Sort By:
Pharmacology, Biochemistry, and Behavior|March 29, 2001
Novel monoamine transporter ligands reduce cocaine-induced enhancement of brain stimulation rewardM Trzcińska, P Pimentel, J R Stellar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Radiographic and Serologic Response to First-Line Chemotherapy in Unresected Localized Pancreatic CancerCaitlin A Hester, Giampaolo Perri, Laura R Prakash, et al.
Cancers|June 28, 2023
Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreatoduodenectomyTom Z Liang, Matthew H G Katz, Laura R Prakash, et al.
Pancreas|June 19, 2019
Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOXTimothy J Vreeland, Florencia McAllister, Sanaz Javadi, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|July 7, 2022
Comparative analysis of opioid use between robotic and open pancreatoduodenectomyRussell G Witt, Yuki Hirata, Laura R Prakash, et al.
Health Information Management : Journal of the Health Information Management Association of Australia|June 13, 2022
Development and implementation of an institutional enhanced recovery program data processMohamed A Seif, Brittany C Kruse, Cameron A Keramati, et al.
The Journal of Surgical Research|March 20, 2022
Association of Patient Controlled Analgesia and Total Inpatient Opioid Use After PancreatectomyRussell G Witt, Timothy E Newhook, Laura R Prakash, et al.
JAMA Surgery|April 15, 2026
Immunotherapy Response in Microsatellite Instability-High Gastroesophageal AdenocarcinomaJun Okui, Laura R Prakash, Heather G Lyu, et al.
Annals of Surgical Oncology|January 3, 2024
Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium StudyDeesje Doppenberg, Thomas F Stoop, Susan van Dieren, et al.
Annals of Surgery|June 30, 2023
Prophylactic Antibiotic Duration and Infectious Complications in Pancreatoduodenectomy Patients With Biliary Stents: Opportunity for De-escalationArtem Boyev, Elsa M Arvide, Timothy E Newhook, et al.
Pageof 34

Showing results (291-300 of 339) with videos related to

Sort By:
Pageof 34
Pharmacology, Biochemistry, and Behavior|March 29, 2001
Novel monoamine transporter ligands reduce cocaine-induced enhancement of brain stimulation rewardM Trzcińska, P Pimentel, J R Stellar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Radiographic and Serologic Response to First-Line Chemotherapy in Unresected Localized Pancreatic CancerCaitlin A Hester, Giampaolo Perri, Laura R Prakash, et al.
Cancers|June 28, 2023
Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreatoduodenectomyTom Z Liang, Matthew H G Katz, Laura R Prakash, et al.
Pancreas|June 19, 2019
Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOXTimothy J Vreeland, Florencia McAllister, Sanaz Javadi, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|July 7, 2022
Comparative analysis of opioid use between robotic and open pancreatoduodenectomyRussell G Witt, Yuki Hirata, Laura R Prakash, et al.
Health Information Management : Journal of the Health Information Management Association of Australia|June 13, 2022
Development and implementation of an institutional enhanced recovery program data processMohamed A Seif, Brittany C Kruse, Cameron A Keramati, et al.
The Journal of Surgical Research|March 20, 2022
Association of Patient Controlled Analgesia and Total Inpatient Opioid Use After PancreatectomyRussell G Witt, Timothy E Newhook, Laura R Prakash, et al.
JAMA Surgery|April 15, 2026
Immunotherapy Response in Microsatellite Instability-High Gastroesophageal AdenocarcinomaJun Okui, Laura R Prakash, Heather G Lyu, et al.
Annals of Surgical Oncology|January 3, 2024
Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium StudyDeesje Doppenberg, Thomas F Stoop, Susan van Dieren, et al.
Annals of Surgery|June 30, 2023
Prophylactic Antibiotic Duration and Infectious Complications in Pancreatoduodenectomy Patients With Biliary Stents: Opportunity for De-escalationArtem Boyev, Elsa M Arvide, Timothy E Newhook, et al.
Pageof 34